Das Gita
Department of Psychiatry, Clinical Psychologist, GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh, India.
J Pharm Bioallied Sci. 2024 Feb;16(Suppl 1):S365-S367. doi: 10.4103/jpbs.jpbs_592_23. Epub 2024 Feb 29.
The present study assessed the benefits of cognitive behavioral treatment in patients suffering from major depressive disorders.
Hundred patients were included in the present study. The cases were assigned alternatively to the experimental group, who received cognitive behavior therapy in addition to the antidepressant medications, whereas in the control group, patients were managed using medications. Four outcome measures were used, viz., Beck Depression Inventory, Hamilton Depression Rating Scale, Beck Anxiety Inventory, and Visual Analog Scale. Chi-square test was used to analyze the data using SPSS.
The highest number of subjects (55%) were found in the age group of 15-25 years. The mean Beck Depression Inventory score in the experimental group was 35.60 (standard deviation 9.52) and in the control group, it was 26.40 (standard deviation 8.26) giving a mean difference of 9.20 which is statistically significant.
It was found that the patients who received cognitive behavior therapy reported greater improvement in their symptomatology than the patients who were receiving medications only.
本研究评估了认知行为疗法对重度抑郁症患者的疗效。
本研究纳入了100名患者。这些病例被交替分配到实验组,该组患者除服用抗抑郁药物外还接受认知行为疗法,而在对照组中,患者仅接受药物治疗。使用了四项结果指标,即贝克抑郁量表、汉密尔顿抑郁评定量表、贝克焦虑量表和视觉模拟量表。使用SPSS软件通过卡方检验对数据进行分析。
发现年龄在15 - 25岁组的受试者数量最多(55%)。实验组的贝克抑郁量表平均得分为35.60(标准差9.52),对照组为26.40(标准差8.26),平均差异为9.20,具有统计学意义。
研究发现,接受认知行为疗法的患者在症状改善方面比仅接受药物治疗的患者更为显著。